Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intravenous Immunoglobin Transfusion in Preterm Infants With Encephalopathy of Prematurity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02822027
Recruitment Status : Unknown
Verified June 2016 by Fang Wu, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.
Recruitment status was:  Recruiting
First Posted : July 4, 2016
Last Update Posted : July 4, 2016
Sponsor:
Information provided by (Responsible Party):
Fang Wu, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Brief Summary:
Infection and inflammation is related to increased encephalopathy of prematurities.

Condition or disease Intervention/treatment Phase
Preterm Infants Drug: human gamma globulin Drug: non-human gamma globulin Not Applicable

Detailed Description:
Animal studies have verified intravenous immunoglobin can reduce brain injury. However, no studies in preterm infants were reported.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Intravenous Immunoglobin Transfusion in Preterm Infants With Encephalopathy of Prematurity
Study Start Date : June 2016
Estimated Primary Completion Date : July 2018

Resource links provided by the National Library of Medicine

Drug Information available for: Rhophylac

Arm Intervention/treatment
Experimental: human gamma globulin
human gamma globulin for infants with encephalopathy of prematurities
Drug: human gamma globulin
human gamma globulin for preterm infants with encephalopathy of prematurities

Drug: non-human gamma globulin
Non-human gamma globulin for preterm infants with encephalopathy of prematurities

Active Comparator: non-human gamma globulin
non-human gamma globulin for infants with encephalopathy of prematurities
Drug: human gamma globulin
human gamma globulin for preterm infants with encephalopathy of prematurities

Drug: non-human gamma globulin
Non-human gamma globulin for preterm infants with encephalopathy of prematurities




Primary Outcome Measures :
  1. structural changes of brain injury [ Time Frame: 100-days ]
    MRI/ultrasound will be used to assess the structural severities of brain injury.

  2. functional changes of brain injury [ Time Frame: 100-days ]
    Bayley score will be used to assess the functional severities of brain injury.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 6 Hours   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • preterm infants with encephalopathy

Exclusion Criteria:

  • refuse the participate in the trial

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02822027


Contacts
Layout table for location contacts
Contact: Wu Fang, MD 8613883559467 476679422@qq.com

Locations
Layout table for location information
China, Chongqing
Department of Pediatrics,Daping Hospital Recruiting
Chongqing, Chongqing, China, 400042
Contact: Wu Fang, MD    8613883559467    476679422@qq.com   
Sponsors and Collaborators
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Layout table for additonal information
Responsible Party: Fang Wu, Principal Investigator, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
ClinicalTrials.gov Identifier: NCT02822027     History of Changes
Other Study ID Numbers: IVIG for encephalopathy
First Posted: July 4, 2016    Key Record Dates
Last Update Posted: July 4, 2016
Last Verified: June 2016

Additional relevant MeSH terms:
Layout table for MeSH terms
Premature Birth
Brain Diseases
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications
Central Nervous System Diseases
Nervous System Diseases
gamma-Globulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
Immunologic Factors
Physiological Effects of Drugs